Pre-exposing leukemic cells with all-trans-retinoic acid (ATRA) has been shown to increase CD38 expression on AML cells and enhance the cytotoxic effects of anti-CD38 CAR T-cells in AML cell lines (26). Here, CD38 is linked to acute myeloid leukemia.